Los Angeles Capital Management LLC reduces Krystal Biotech holdings by 2.3% in second quarter
🌥️Trending News Krystal Biotech ($NASDAQ:KRYS), Inc. is a biotechnology company specializing in gene therapies for rare dermatological diseases. Headquartered in [...]
Krystal Biotech Soars to the Top of the Biotech Industry!
☀️Trending News Krystal Biotech ($NASDAQ:KRYS) Inc. is quickly becoming a major player in the biotechnology sector. The company has experienced [...]
Krystal Biotech’s Vyjuvek Exceeds Expectations, Strengthens Prospects
☀️Trending News Krystal Biotech ($NASDAQ:KRYS) has recently seen a surge in success with their new product Vyjuvek, which is already [...]
Krystal Biotech Intrinsic Value Calculation – KRYSTAL BIOTECH Reports Record-Breaking Revenue of USD 8.6 Million for FY2023 Q3
🌥️Earnings Overview On November 6, 2023, KRYSTAL BIOTECH ($NASDAQ:KRYS) announced their earnings results for FY2023 Q3, reporting total revenue of [...]
Cantor Fitzgerald Gives KRYSTAL BIOTECH an Overweight Rating
🌧️Trending News Cantor Fitzgerald has assigned an Overweight rating to Krystal Biotech ($NASDAQ:KRYS), a biopharmaceutical company based in California. The [...]
Krystal Biotech Intrinsic Value Calculation – Krystal Biotech Earnings Beat Estimates by $0.02, Revenue In Line with Expectations
🌥️Trending News Krystal Biotech ($NASDAQ:KRYS), Inc. is an innovative biotechnology company focused on developing and commercializing gene therapies to treat [...]
Voya Investment Management LLC Decreases Stake in Krystal Biotech, by 2.0% in Q4
🌥️Trending News Krystal Biotech ($NASDAQ:KRYS), Inc. is a gene therapy company, focused on developing and commercializing transformative treatments to cure [...]
KRYSTAL BIOTECH Receives FDA Approval for Topical Gene Therapy to Treat Rare Skin Disorder
Trending News ☀️ Krystal Biotech ($NASDAQ:KRYS), Inc., a gene therapy company, recently received approval from the US Food and Drug [...]
Krystal Biotech Transforms Rare Disease Treatment with Genetic Medicine
Trending News 🌥️ Krystal Biotech ($NASDAQ:KRYS) is leading the charge in transforming rare disease treatment through genetic medicine. This innovative [...]
Krystal Biotech Intrinsic Value – KRYSTAL BIOTECH Takes Step Forward with Filing of Automatic Mixed Securities Shelf
Trending News ☀️ Krystal Biotech ($NASDAQ:KRYS), a biotechnology company focused on developing and commercializing gene therapies to treat dermatological conditions, [...]
